Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $68.62 +4.30%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of $0.41, $0.44 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $151.81 million versus the consensus estimate of $112.72 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- The Fed is hiking. Why isn't UBS worried about stocks?
- Astrana Health (ASTH) Mentioned as short at Glass House
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
